S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$107.29
+1.9%
$114.28
$89.67
$121.64
$186.17B0.745.76 million shs10.53 million shs
Anterix Inc. stock logo
ATEX
Anterix
$31.72
+1.3%
$34.89
$27.20
$40.45
$587.45M0.68109,923 shs105,460 shs
Camtek Ltd. stock logo
CAMT
Camtek
$74.68
-5.7%
$80.96
$25.25
$90.54
$3.55B1.41430,081 shs643,764 shs
Ebix, Inc. stock logo
EBIX
Ebix
$3.51
$1.05
$32.87
$35.85M2.371.20 million shs12.34 million shs
Forrester Research, Inc. stock logo
FORR
Forrester Research
$18.75
+0.8%
$20.29
$18.30
$33.75
$363.64M0.91149,955 shs111,677 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-0.59%-5.52%-6.94%-8.26%-6.25%
Anterix Inc. stock logo
ATEX
Anterix
-0.98%-5.64%-8.80%+5.71%0.00%
Camtek Ltd. stock logo
CAMT
Camtek
-1.48%-2.25%+1.67%+0.58%+215.17%
Ebix, Inc. stock logo
EBIX
Ebix
0.00%0.00%0.00%0.00%-93.39%
Forrester Research, Inc. stock logo
FORR
Forrester Research
+0.43%-4.52%-10.14%-25.23%-43.74%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4.9951 of 5 stars
3.45.04.24.53.12.52.5
Anterix Inc. stock logo
ATEX
Anterix
2.9378 of 5 stars
3.32.00.00.03.33.31.3
Camtek Ltd. stock logo
CAMT
Camtek
1.7383 of 5 stars
1.51.01.70.02.72.52.5
Ebix, Inc. stock logo
EBIX
Ebix
1.6404 of 5 stars
3.00.00.80.00.62.51.3
Forrester Research, Inc. stock logo
FORR
Forrester Research
4.8423 of 5 stars
3.05.00.84.41.73.32.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.75
Moderate Buy$121.3113.07% Upside
Anterix Inc. stock logo
ATEX
Anterix
2.50
Moderate Buy$58.0082.85% Upside
Camtek Ltd. stock logo
CAMT
Camtek
3.00
Buy$74.750.09% Upside
Ebix, Inc. stock logo
EBIX
Ebix
2.00
Hold$5.00∞ Upside
Forrester Research, Inc. stock logo
FORR
Forrester Research
2.00
Hold$37.0097.33% Upside

Current Analyst Ratings

Latest FORR, ABT, EBIX, CAMT, and ATEX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/18/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$128.00 ➝ $125.00
4/16/2024
Camtek Ltd. stock logo
CAMT
Camtek
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$100.00
4/4/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$120.00 ➝ $125.00
4/3/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$126.00 ➝ $128.00
3/26/2024
Camtek Ltd. stock logo
CAMT
Camtek
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$102.00
2/21/2024
Camtek Ltd. stock logo
CAMT
Camtek
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$82.00 ➝ $90.00
2/21/2024
Camtek Ltd. stock logo
CAMT
Camtek
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$94.00 ➝ $102.00
2/16/2024
Anterix Inc. stock logo
ATEX
Anterix
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$75.00
2/14/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$128.00
1/26/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$133.00 ➝ $141.00
1/25/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$123.00 ➝ $126.00
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$40.11B4.64$6.44 per share16.65$22.36 per share4.80
Anterix Inc. stock logo
ATEX
Anterix
$1.92M305.97N/AN/A$9.53 per share3.33
Camtek Ltd. stock logo
CAMT
Camtek
$315.38M10.63$1.88 per share39.76$10.69 per share6.99
Ebix, Inc. stock logo
EBIX
Ebix
$735.63M0.00N/A0.35$21.34 per share0.00
Forrester Research, Inc. stock logo
FORR
Forrester Research
$480.78M0.76$3.04 per share6.16$12.49 per share1.50

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$5.72B$3.2133.4220.872.5513.96%20.32%10.59%7/18/2024 (Estimated)
Anterix Inc. stock logo
ATEX
Anterix
-$16.32M$0.8437.76N/AN/A447.16%-17.22%-10.54%6/12/2024 (Estimated)
Camtek Ltd. stock logo
CAMT
Camtek
$78.63M$1.6246.1030.862.7624.93%18.92%11.40%5/8/2024 (Estimated)
Ebix, Inc. stock logo
EBIX
Ebix
$64.64M$0.176.82N/AN/A0.67%4.15%1.79%N/A
Forrester Research, Inc. stock logo
FORR
Forrester Research
$3.05M$0.17110.2915.761.320.63%10.77%4.41%4/30/2024 (Confirmed)

Latest FORR, ABT, EBIX, CAMT, and ATEX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/30/2024N/A
Forrester Research, Inc. stock logo
FORR
Forrester Research
$0.2170N/A-$0.2170N/AN/AN/A  
4/17/2024Q1 24
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$0.96$0.98+$0.02$1.26$9.88 billion$9.96 billion    
2/20/202412/31/2023
Camtek Ltd. stock logo
CAMT
Camtek
$0.53$0.57+$0.04$0.60$88.02 million$88.70 million    
2/14/2024Q3 2024
Anterix Inc. stock logo
ATEX
Anterix
-$0.61-$0.55+$0.06-$1.12$1.20 million$1.27 million
2/8/2024Q4 2023
Forrester Research, Inc. stock logo
FORR
Forrester Research
$0.11$0.09-$0.02$0.21$116.43 million$118.09 million
1/24/202412/31/2023
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.19$1.19N/A$1.47$10.19 billion$10.24 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.202.05%+12.31%68.54%53 Years
Anterix Inc. stock logo
ATEX
Anterix
N/AN/AN/AN/AN/A
Camtek Ltd. stock logo
CAMT
Camtek
$1.331.78%N/A82.10%N/A
Ebix, Inc. stock logo
EBIX
Ebix
$0.07N/AN/A41.18%N/A
Forrester Research, Inc. stock logo
FORR
Forrester Research
$0.804.27%N/A470.59%N/A

Latest FORR, ABT, EBIX, CAMT, and ATEX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/16/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.551.9%4/12/20244/15/20245/15/2024
3/21/2024
Camtek Ltd. stock logo
CAMT
Camtek
Variable$1.334/3/20244/4/20244/18/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.35
1.64
1.16
Anterix Inc. stock logo
ATEX
Anterix
N/A
4.51
4.51
Camtek Ltd. stock logo
CAMT
Camtek
0.41
5.66
4.77
Ebix, Inc. stock logo
EBIX
Ebix
N/A
0.41
0.41
Forrester Research, Inc. stock logo
FORR
Forrester Research
0.15
0.90
0.90

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Anterix Inc. stock logo
ATEX
Anterix
87.67%
Camtek Ltd. stock logo
CAMT
Camtek
41.93%
Ebix, Inc. stock logo
EBIX
Ebix
66.08%
Forrester Research, Inc. stock logo
FORR
Forrester Research
55.20%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
1.10%
Anterix Inc. stock logo
ATEX
Anterix
31.71%
Camtek Ltd. stock logo
CAMT
Camtek
79.40%
Ebix, Inc. stock logo
EBIX
Ebix
15.90%
Forrester Research, Inc. stock logo
FORR
Forrester Research
39.20%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
114,0001.74 billion1.72 billionOptionable
Anterix Inc. stock logo
ATEX
Anterix
8218.52 million12.65 millionOptionable
Camtek Ltd. stock logo
CAMT
Camtek
56544.90 million9.25 millionOptionable
Ebix, Inc. stock logo
EBIX
Ebix
10,52130.90 million25.99 millionNot Optionable
Forrester Research, Inc. stock logo
FORR
Forrester Research
1,74419.39 million11.79 millionOptionable

FORR, ABT, EBIX, CAMT, and ATEX Headlines

SourceHeadline
Will AI PCs actually be any help in the workplace? This report says not yetWill AI PCs actually be any help in the workplace? This report says not yet
msn.com - April 19 at 4:04 PM
As NSA Pushes for Microsegmentation, Will Others Follow?As NSA Pushes for Microsegmentation, Will Others Follow?
inforisktoday.com - April 18 at 6:19 PM
3 reasons companies are investing in AI-powered PCs3 reasons companies are investing in AI-powered PCs
businessinsider.com - April 18 at 6:19 PM
AI PCs are here but a killer application for biz users? NopeAI PCs are here but a killer application for biz users? Nope
msn.com - April 18 at 8:18 AM
How Localization Automation Can Get Companies a 345% ROIHow Localization Automation Can Get Companies a 345% ROI
slator.com - April 17 at 10:19 AM
UKG Named a Leader in HCM for Third Consecutive YearUKG Named a Leader in HCM for Third Consecutive Year
tmcnet.com - April 16 at 6:58 PM
RJ Forrester Is Paying for the Sins of His Father on Bold and the BeautifulRJ Forrester Is Paying for the Sins of His Father on Bold and the Beautiful
msn.com - April 16 at 6:58 PM
Forrester Research To Broadcast Its 2024 First-Quarter Earnings Conference CallForrester Research To Broadcast Its 2024 First-Quarter Earnings Conference Call
finance.yahoo.com - April 16 at 1:58 PM
Beyond Git: How version control systems are evolving for devopsBeyond Git: How version control systems are evolving for devops
infoworld.com - April 15 at 10:04 AM
With 51% ownership of the shares, Forrester Research, Inc. (NASDAQ:FORR) is heavily dominated by institutional ownersWith 51% ownership of the shares, Forrester Research, Inc. (NASDAQ:FORR) is heavily dominated by institutional owners
finance.yahoo.com - April 14 at 2:09 PM
Forrester Research (NASDAQ:FORR) Stock Rating Upgraded by StockNews.comForrester Research (NASDAQ:FORR) Stock Rating Upgraded by StockNews.com
americanbankingnews.com - April 13 at 1:38 AM
Does your multinational org truly have a global payroll system?Does your multinational org truly have a global payroll system?
hrexecutive.com - April 12 at 1:54 PM
The customer data platform marketThe customer data platform market
msn.com - April 12 at 1:54 PM
Forrester Research, Inc. (NASDAQ:FORR) Sees Large Decrease in Short InterestForrester Research, Inc. (NASDAQ:FORR) Sees Large Decrease in Short Interest
marketbeat.com - April 11 at 11:20 PM
Forrester Research (NASDAQ:FORR) Raised to "Buy" at StockNews.comForrester Research (NASDAQ:FORR) Raised to "Buy" at StockNews.com
marketbeat.com - April 11 at 11:12 PM
Qlik Partners with Forrester to Highlight Economic Impact of Cloud Analytics SolutionsQlik Partners with Forrester to Highlight Economic Impact of Cloud Analytics Solutions
datanami.com - April 11 at 7:53 PM
5 Best Practices for Empathetic Experience Design5 Best Practices for Empathetic Experience Design
destinationcrm.com - April 11 at 2:52 PM
Duane Forrester discusses SEO’s future at Yext summitDuane Forrester discusses SEO’s future at Yext summit
dmnews.com - April 11 at 2:52 PM
Duane Forrester provides insight into enhancing SEO strategiesDuane Forrester provides insight into enhancing SEO strategies
dmnews.com - April 11 at 9:52 AM
Duane Forrester shares vital SEO upskilling insightsDuane Forrester shares vital SEO upskilling insights
dmnews.com - April 11 at 9:52 AM
B2B E-Commerce: Key Reports Indicate Many Web Stores BrokenB2B E-Commerce: Key Reports Indicate Many Web Stores Broken
ecommercetimes.com - April 10 at 2:05 PM
Head to Head Comparison: Forrester Research (NASDAQ:FORR) and DKSH (OTCMKTS:DKSHF)Head to Head Comparison: Forrester Research (NASDAQ:FORR) and DKSH (OTCMKTS:DKSHF)
americanbankingnews.com - April 10 at 1:24 AM
TikTok to take on Instagram with photo appTikTok to take on Instagram with photo app
msn.com - April 9 at 2:48 PM
H2O.AI NAMED LEADER IN COMPUTER VISION TOOLS BY FORRESTER RESEARCHH2O.AI NAMED LEADER IN COMPUTER VISION TOOLS BY FORRESTER RESEARCH
bernama.com - April 9 at 12:58 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Abbott Laboratories logo

Abbott Laboratories

NYSE:ABT
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Anterix logo

Anterix

NASDAQ:ATEX
Anterix Inc. operates as a wireless communications company. The company focuses on commercializing its spectrum assets to enable the targeted utility and critical infrastructure customers to deploy private broadband networks and innovative broadband solutions. It holds licensed spectrum in the 900 MHz band with coverage throughout the United States, Alaska, Hawaii, and Puerto Rico. The company was formerly known as pdvWireless, Inc. and changed its name to Anterix Inc. in August 2019. Anterix Inc. was incorporated in 1997 and is headquartered in Woodland Park, New Jersey.
Camtek logo

Camtek

NASDAQ:CAMT
Camtek Ltd., together with its subsidiaries, develops, manufactures, and sells inspection and metrology equipment for semiconductor industry. The company provides Eagle-i, a system that delivers 2D inspection and metrology capabilities; Eagle-AP, which addresses the advanced packaging market using software and hardware technologies that deliver superior 2D and 3D inspection and metrology capabilities on the same platform; and Golden Eagle, a panel inspection and metrology system to address the challenges fanout wafer level packaging applications. It also develops automatic defect classification, which provides automatic defect classification of color images utilizing deep learning techniques to reduce and eliminate manual verification. In addition, the company offers MicroProf AP, a wafer metrology tool for applications at 3D packaging process steps; MicroProf DI, an optical inspection tool that enables inspection of structured and unstructured wafers for manufacturing process; MicroProf FE, a 2D/3D wafer metrology tool that serve front end HVM fab; MicroProf FS, an wafer metrology tool configurable for wafer foundry; MicroProf PT for hybrid metrology applications to common panel sizes; MicroProf MHU metrology tool, a material handling unit for semiconductor, MEMS, sapphire, and LED industries; MicroProf TL, an optical surface measurement tool for fully automatic 3D surface measurements; MicroProf 100, a universal surface metrology tool for determination of topography and film and sample thickness; MicroProf 200, a measuring device for contactless and non-destructive characterization of surfaces and films; and MicroProf 300, a SurfaceSens technology for quality assurance, development, and manufacturing. It serves semiconductor manufacturers, outsourced semiconductor assembly and test, integrated device manufacturers, and wafer level packaging subcontractors. Camtek Ltd. was incorporated in 1987 and is headquartered in Migdal Haemek, Israel.
Ebix logo

Ebix

NASDAQ:EBIX
Ebix, Inc., together with its subsidiaries, provides on-demand infrastructure software exchanges and e-commerce services to the insurance, financial, travel, cash remittance, and healthcare industries in the United States and internationally. The company develops and deploys insurance and reinsurance exchanges on an on-demand basis using software-as-a-service (SaaS) enterprise solutions in the areas of customer relationship management, front-end and back-end systems, and outsourced administrative and risk compliance solutions. Its EbixCash exchange related products and services include gift cards; travel exchanges services; money transfer services; foreign exchange and outward remittance services; consumer payment services; and on-demand technology to various providers in the areas of lending, wealth and asset management, and travel. The company's insurance exchanges related products and services include SaaS platform and related services; licensing of software; and professional services comprising setup, customization, training, or consulting. Its risk compliance services cover certificates of insurance creation and tracking; consulting services, such as project management, integration, development, and testing; and business process outsourcing services, including domain intensive project management, system consulting services, and claims adjudication/settlement services. The company was formerly known as Delphi Systems, Inc. and changed its name to Ebix, Inc. in December 2003. Ebix, Inc. was founded in 1976 and is headquartered in Johns Creek, Georgia. On December 17, 2023, Ebix, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Northern District of Texas.
Forrester Research logo

Forrester Research

NASDAQ:FORR
Forrester Research, Inc. operates as an independent research and advisory company in the United States and internationally. The company operates in three segments: Research, Consulting, and Events. The Research segment primary subscription research services include Forrester Decisions, Forrester Research, and SiriusDecisions Research, which are designed to provide business and technology leaders with a proven path to growth through customer obsession. This segment delivers content, such as future trends, predictions, and market forecasts; deep consumer and business buyer data and insights; curated best practice models and tools to run business functions; operational and performance benchmarking data; and technology and service market landscapes and vendor evaluations. The Consulting segment provides consulting projects, include conducting maturity assessments, prioritizing best practices, developing strategies, building business cases, selecting technology vendors, structuring organizations, developing content marketing strategies and collateral, and sales tools; and advisory services. The Events segment hosts events related to business-to-business marketing, sales and product leadership, customer experience, security and risk, new technology and innovation, and data strategies and insights. The company sells its products and services through direct sales force in various locations. Forrester Research, Inc. was incorporated in 1983 and is headquartered in Cambridge, Massachusetts.